(EMXC) MSCI Emerging Markets ex - Overview
Etf: Equities, Options, Swaps, Futures, Cash
Dividends
| Dividend Yield | 3.08% |
| Yield on Cost 5y | 3.84% |
| Yield CAGR 5y | 17.28% |
| Payout Consistency | 91.8% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 16.6% |
| Relative Tail Risk | 1.78% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.14 |
| Alpha | 36.23 |
| Character TTM | |
|---|---|
| Beta | 0.682 |
| Beta Downside | 0.664 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.12% |
| CAGR/Max DD | 1.10 |
Description: EMXC MSCI Emerging Markets ex January 02, 2026
The iShares MSCI Emerging Markets ex China ETF (NASDAQ: EMXC) tracks a free-float-adjusted, market-cap weighted index that covers large- and mid-cap stocks in 23 of the 24 emerging-market countries, explicitly leaving out China. The fund is required to hold at least 80 % of its assets in the index’s component securities-or securities that are economically indistinguishable from them-and may allocate up to the remaining 20 % to futures, options, swaps, cash, or cash equivalents for liquidity and risk-management purposes.
Key metrics (as of the latest quarter): total net assets ≈ $3.2 billion, expense ratio 0.35 %, and a 12-month trailing return of about +5.8 % (USD). The ETF’s top sector exposures are financials (~ 23 %), information technology (~ 15 %), and consumer discretionary (~ 12 %).
Fundamental drivers for the ex-China emerging-market universe include: (1) commodity price cycles that heavily influence resource-rich economies such as Brazil and Russia; (2) domestic consumption growth tied to rising middle-class incomes in India, Indonesia and Vietnam; and (3) monetary-policy divergence, where many of these markets maintain higher real rates than advanced economies, supporting currency stability and equity valuations.
For a deeper, data-rich breakdown of EMXC’s risk-adjusted performance and sector-level sensitivities, you might find the analytics on ValueRay worth a look.
What is the price of EMXC shares?
Over the past week, the price has changed by +2.51%, over one month by +7.35%, over three months by +17.19% and over the past year by +48.15%.
Is EMXC a buy, sell or hold?
What are the forecasts/targets for the EMXC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 98.7 | 20.7% |
EMXC Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 15.14b USD (15.14b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 15.14b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 15.14b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.43% (E(15.14b)/V(15.14b) * Re(8.43%) + (debt-free company))
Discount Rate = 8.43% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)